Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

BACKGROUND: India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sundar, Shyam, Pandey, Krishna, Thakur, Chandreshwar Prasad, Jha, Tara Kant, Das, Vidya Nand Ravi, Verma, Neena, Lal, Chandra Shekhar, Verma, Deepak, Alam, Shahnawaz, Das, Pradeep
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169371/
https://ncbi.nlm.nih.gov/pubmed/25233346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0003169
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars